PimedBio

  • ABOUT US
    About Us

    We create new treatments
    based on cutting-edge approaches.

    • STARTUP STORY
    • HISTORY
    • LEADERSHIP
    • PARTNERSHIP & COLLABORATION
    • LOCATION
  • PLATFORM
    Platform

    We create new treatments
    based on cutting-edge approaches.

    • Platform Technology
  • PIPELINE
    Pipeline

    We create new treatments
    based on cutting-edge approaches.

    • OVERVIEW
    • Oncology
    • IMMUNOLOGY
  • PR
    PR

    We create new treatments
    based on cutting-edge approaches.

    • News
    • Notice
    • IR
  • CAREER
    CAREER

    We create new treatments
    based on cutting-edge approaches.

    • Recruitment notice
    • Join us
EN
  • KR
  • About Us
    • Startup story
    • History
    • Leadership
    • Partnership & Collaboration
    • Location
  • Platform
    • Platform technology
  • Pipeline
    • Overview
    • Oncology
      • PMB212
      • PMB298
      • Discovery of new drug platforms
    • Immunology
      • PMB702
  • PR
    • News
    • Notice
    • IR
  • Career
    • Recruitment notice
    • Join Us

PR

Shaping Tomorrow with
Next-Gen Therapeutics
  • News
  • Notice
  • IR
  • home
  • PR
  • Notice

Notice

  • Notice
    2026.03.25
    PimedBio Secures U.S. Patent for Novel Drug Candidate
  • Notice
    2025.09.01
    PimedBio Receives U.S. FDA IND Approval for First-in-Class Cancer Stem..
  • Notice
    2024.08.15
    PimedBio Selected for Johnson & Johnson Innovation’s Global Network, J..
  • Notice
    2023.12.19
    PimedBio’s Cancer Stemness Inhibitor Selected as one of KDDF’s "T..
  • Notice
    2022.02.08
    PimedBio Signs MOU with K-MEDI Hub for CDMO Services and Drug Developm..
  • Notice
    2018.02.10
    PimedBio Joins Institut Pasteur Korea’s ‘Bio Core Facility’ Program
1

2nd floor, H2233, Healthcare Innovation Park, Bundang Seoul National University Hospital, 172 Dolmaro, Bundang-gu, Seongnam-si, Gyeonggi-do
Tel. +82-31-8039-7240
  • 개인정보처리방침
  • 이메일무단수집거부
Copyright(C) Pimedbio. All Rights Reseved.